<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Arcadia Biosciences, Inc. — News on 6ix</title>
<link>https://6ix.com/company/arcadia-biosciences-inc</link>
<description>Latest news and press releases for Arcadia Biosciences, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 14 May 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/arcadia-biosciences-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835b88e78dffbe2df115074.webp</url>
<title>Arcadia Biosciences, Inc.</title>
<link>https://6ix.com/company/arcadia-biosciences-inc</link>
</image>
<item>
<title>Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-first-quarter-2026-financial-results-and-business-highlights</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-first-quarter-2026-financial-results-and-business-highlights</guid>
<pubDate>Thu, 14 May 2026 20:05:00 GMT</pubDate>
<description>-- Zola® volumes increase 18% year-over-year -- -- SG&A at lowest level in Arcadia’s history -- DALLAS, May 14, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the first quarter of 2026. “We are very pleased with our performance during the first quarter of 2026,” said T.J. Schaefer, CEO of Arcadia. “We were able to bring in gross proceeds of approximately $2.1 millio</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-fourth-quarter-and-full-year-2025-financial-results-and-business-highlights</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-fourth-quarter-and-full-year-2025-financial-results-and-business-highlights</guid>
<pubDate>Thu, 26 Mar 2026 04:00:00 GMT</pubDate>
<description>-- Zola® revenues increase 17% year-over-year -- -- Arcadia and Roosevelt Resources terminate proposed business combination -- -- Exercise of preferred</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-exercise-130000009</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-exercise-130000009</guid>
<pubDate>Mon, 12 Jan 2026 13:00:00 GMT</pubDate>
<description>DALLAS, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that it has entered into definitive agreements for the immediate exercise of certain outstanding preferred investment options to purchase up to an aggregate of 808,595 shares originally issued in December 2020, January 2021, August 2022 and March 2023, having an exercise price of $9.00 per share, at a reduced exercise price of $2.575 per sh</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-receives-termination-130200980</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-receives-termination-130200980</guid>
<pubDate>Fri, 26 Dec 2025 13:02:00 GMT</pubDate>
<description>DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that on December 24, 2025, it received a notice from Roosevelt Resources, LP, terminating the Securities Exchange Agreement between Arcadia and Roosevelt dated December 4, 2024, pursuant to the terms of the agreement. The agreement provided for a proposed business combination transaction between the two companies. “In light of these circums</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-third-210500943</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-third-210500943</guid>
<pubDate>Fri, 07 Nov 2025 21:05:00 GMT</pubDate>
<description>-- Zola® year-to-date revenues increase 26% year over year ---- Arcadia gross profit margins exceed 30% for 11th straight quarter ---- Arcadia cash balance declines by only $257K to $1.1M -- DALLAS, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the third quarter of 2025. “We are very pleased with our performance for the third quarter of 2025.” said T.J. Sc</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-second-203000330</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-second-203000330</guid>
<pubDate>Thu, 14 Aug 2025 20:30:00 GMT</pubDate>
<description>-- Arcadia revenues increase 11% year over year driven by 24% growth in Zola® -- -- Arcadia receives 2.7 million shares of stock in ABVE -- -- Arcadia eliminates $1M in liabilities -- DALLAS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the second quarter and first half of 2025. “We are very pleased with our performance for the second quarter of 2025,” sa</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-first-120200885</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-first-120200885</guid>
<pubDate>Thu, 08 May 2025 12:02:00 GMT</pubDate>
<description>-- Revenues increase 22% year over year driven by 90% growth in Zola® ---- Arcadia sells patents for $750K and eliminates $1M in liabilities ---- Roosevelt agreement amended to provide greater certainty regarding exchange ratio -- DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the first quarter of 2025. The company has schedul</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-date-120200052</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-date-120200052</guid>
<pubDate>Tue, 29 Apr 2025 12:02:00 GMT</pubDate>
<description>DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2025 on May 8, 2025. The company has scheduled a conference call for 2:00 p.m. Eastern time (11:00 a.m. Pacific time) to discuss first-quarter results and key strategic achievements. Interested participants can join the conference call</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-fourth-200500257</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-fourth-200500257</guid>
<pubDate>Thu, 20 Mar 2025 20:05:00 GMT</pubDate>
<description>DALLAS, March 20, 2025--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2024.</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2024 Financial Results and Business Highlights Conference Call</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-date-130200941</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-date-130200941</guid>
<pubDate>Thu, 06 Mar 2025 13:02:00 GMT</pubDate>
<description>DALLAS, March 06, 2025--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the fourth quarter and full year of 2024 after market close on March 20, 2025.</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Enters Into Business Combination Agreement with Roosevelt Resources in All-Stock Transaction</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-enters-into-business-combination-agreement-with-roosevelt-resources-in-all-stock-transaction</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-enters-into-business-combination-agreement-with-roosevelt-resources-in-all-stock-transaction</guid>
<pubDate>Thu, 05 Dec 2024 05:00:00 GMT</pubDate>
<description>-- Companies to host a joint investor call on December 11, 2024 at 4:30 p.m. ET -- DALLAS--(BUSINESS WIRE)-- Arcadia Biosciences, Inc.® (Nasdaq: RKDA) and</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2024 Financial Results and Business Highlights</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-strong-third-quarter-2024-financial-results-and-business-highlights</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-strong-third-quarter-2024-financial-results-and-business-highlights</guid>
<pubDate>Tue, 12 Nov 2024 05:00:00 GMT</pubDate>
<description>– Total revenues increased 18% compared to Q3 2023 – – Zola® coconut water revenues grew 55% year over year – – Zola retail distribution expanded 68% vs. Q3</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2024 Financial Results and Business Highlights Conference Call</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-date-of-third-quarter-2024-financial-results-and-business-highlights-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-date-of-third-quarter-2024-financial-results-and-business-highlights-conference-call</guid>
<pubDate>Tue, 29 Oct 2024 04:00:00 GMT</pubDate>
<description>DALLAS--(BUSINESS WIRE)-- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2024 Financial Results and Business Highlights</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-second-quarter-and-first-half-2024-financial-results-and-business-highlights</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-second-quarter-and-first-half-2024-financial-results-and-business-highlights</guid>
<pubDate>Tue, 13 Aug 2024 04:00:00 GMT</pubDate>
<description>-- Company closes $4M transaction with Corteva Agriscience -- -- Above Food Corp acquires GoodWheatTM brand -- -- Zola® coconut water sales increase 42% year</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2024 Financial Results and Business Highlights Conference Call</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-date-of-second-quarter-2024-financial-results-and-business-highlights-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-date-of-second-quarter-2024-financial-results-and-business-highlights-conference-call</guid>
<pubDate>Tue, 30 Jul 2024 04:00:00 GMT</pubDate>
<description>DALLAS--(BUSINESS WIRE)-- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces Leadership Transition</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-leadership-transition</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-leadership-transition</guid>
<pubDate>Tue, 09 Jul 2024 04:00:00 GMT</pubDate>
<description>-- CEO Stan Jacot replaced by CFO Thomas J. Schaefer -- DALLAS--(BUSINESS WIRE)-- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces Sale of GoodWheatTM to Above Food Corp.</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-sale-of-goodwheattm-to-above-food-corp</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-sale-of-goodwheattm-to-above-food-corp</guid>
<pubDate>Thu, 16 May 2024 04:00:00 GMT</pubDate>
<description>-- Transaction will accelerate scaling Arcadia’s wheat IP with Above’s vertically integrated, farm-to-fork supply chain -- DALLAS--(BUSINESS WIRE)-- Arcadia</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces Sale of Resistant Starch Durum Wheat Trait to Corteva Agriscience (CTVA)</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-sale-of-resistant-starch-durum-wheat-trait-to-corteva-agriscience-ctva</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-sale-of-resistant-starch-durum-wheat-trait-to-corteva-agriscience-ctva</guid>
<pubDate>Tue, 14 May 2024 04:00:00 GMT</pubDate>
<description>-- Company advances monetization of wheat technology with one-time payment of $4 million -- DALLAS--(BUSINESS WIRE)-- Arcadia Biosciences, Inc.® (Nasdaq:</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces First Quarter 2024 Financial Results and Business Highlights</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-first-quarter-2024-financial-results-and-business-highlights</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-first-quarter-2024-financial-results-and-business-highlights</guid>
<pubDate>Thu, 09 May 2024 04:00:00 GMT</pubDate>
<description>– Revenues increase sequentially and year-over-year – – Loss from continuing operations is at lowest level in 6 years – DALLAS--(BUSINESS WIRE)-- Arcadia</description>
</item>
<item>
<title>Arcadia Biosciences (RKDA) Announces Date of First Quarter 2024 Financial Results and Business Highlights Conference Call</title>
<link>https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-date-of-first-quarter-2024-financial-results-and-business-highlights-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/arcadia-biosciences-inc/news/arcadia-biosciences-rkda-announces-date-of-first-quarter-2024-financial-results-and-business-highlights-conference-call</guid>
<pubDate>Thu, 25 Apr 2024 04:00:00 GMT</pubDate>
<description>DALLAS--(BUSINESS WIRE)-- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today</description>
</item>
</channel>
</rss>